Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Citicoline Sodium
Therapeutic Area : Ophthalmology
Study Phase : Phase III
Sponsor : OPIS Spain
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
February 02, 2023
Lead Product(s) : Citicoline Sodium
Therapeutic Area : Ophthalmology
Highest Development Status : Phase III
Sponsor : OPIS Spain
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Citicoline Sodium
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Biofortis Clinical Research, Inc.
Deal Size : Inapplicable
Deal Type : Inapplicable
Cognitive Effects of Citicoline on Attention in Healthy Mean and Women
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
July 19, 2021
Lead Product(s) : Citicoline Sodium
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Biofortis Clinical Research, Inc.
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Citicoline Sodium
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Oregon Health and Science University
Deal Size : Inapplicable
Deal Type : Inapplicable
The Combination Effect of Citicoline and Omega-3
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
February 23, 2018
Lead Product(s) : Citicoline Sodium
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Oregon Health and Science University
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Citicoline Sodium
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Biofortis Clinical Research, Inc.
Deal Size : Inapplicable
Deal Type : Inapplicable
Cognitive Effects of Citicoline in Men and Women With Age-Associated Memory Impairment
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
December 12, 2017
Lead Product(s) : Citicoline Sodium
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Biofortis Clinical Research, Inc.
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Citicoline Sodium
Therapeutic Area : Musculoskeletal
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
July 26, 2016
Lead Product(s) : Citicoline Sodium
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Citicoline Sodium
Therapeutic Area : Musculoskeletal
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
July 26, 2016
Lead Product(s) : Citicoline Sodium
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Citicoline Sodium
Therapeutic Area : Musculoskeletal
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
July 26, 2016
Lead Product(s) : Citicoline Sodium
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Citicoline Sodium
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : University of Cincinnati
Deal Size : Inapplicable
Deal Type : Inapplicable
Citicoline Effects on Cortical Membrane Structure and Function
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
March 10, 2016
Lead Product(s) : Citicoline Sodium
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : University of Cincinnati
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Citicoline Sodium
Therapeutic Area : Oncology
Study Phase : Undisclosed
Sponsor : DENSMORE pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
April 19, 2011
Lead Product(s) : Citicoline Sodium
Therapeutic Area : Oncology
Highest Development Status : Undisclosed
Sponsor : DENSMORE pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable